Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer
暂无分享,去创建一个
S. Paik | N. Wolmark | K. Pogue-Geile | Rim S. Kim | A. Srinivasan | A. Robidoux | F. Piette | C. Allegra | S. Di Cosimo | A. Llombart-Cussac | J. Abraham | J. Cortés | N. Song | H. Feng | S. Antolín | M. Cazzaniga | P. Gavin | Corey Lipchik | S. Jacobs | N. La Verde | E. Aguirre | Ying Wang | J. Peréz-García | J. Orcutt | P. C. Lucas | April D. Balousek